Strategies and hurdles using DNA vaccines to fish

Veterinary Research

Volumn 45, Issue 1, 2014, Pages

  Hølvold, Linn B ^a   Myhr, Anne I ^b   Dalmo, Roy A ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b Genøk Center for Biosafety   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; LACTIC ACID; MICROSPHERE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL; EVALUATION STUDY; FISH; FISH DISEASE; FISHERY; METHODOLOGY; REVIEW; VIRUS INFECTION;

ANIMALS; FISH DISEASES; FISHERIES; FISHES; LACTIC ACID; MICROSPHERES; POLYGLYCOLIC ACID; VACCINES, DNA; VIRUS DISEASES;

EID: 84896796786     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-45-21     Document Type: Article

References (98)

1. DNA vaccines against viral diseases of farmed fish. Evensen Ø Leong JA, Fish Shellfish Immun 2013 35 1751 1758 10.1016/j.fsi.2013.10.021
2. Approaches to improved targeting of DNA vaccines. Wang G, Pan L, Zhang Y, Hum Vaccin 2011 7 1271 1281 10.4161/hv.7.12.17983 22108038
3. Regulation of DNA vaccines and gene therapy on animals. Board TNBA, 2003 [ http://www.bion.no/filarkiv/2010/07/2006-03-regulation-of-DNA-vaccines.pdf ]
4. Trout oral VP2 DNA vaccination mimics transcriptional responses occurring after infection with infectious pancreatic necrosis virus (IPNV). Ballesteros NA, Saint-Jean SS, Perez-Prieto SI, Coll JM, Fish Shellfish Immunol 2012 33 1249 1257 10.1016/j.fsi.2012.09.004 23041507
5. Development of DNA vaccines for fish: vector design, intramuscular injection and antigen expression using viral haemorrhagic septicaemia virus genes as model. Heppell J, Lorenzen N, Armstrong NK, Wu T, Lorenzen E, Einer-Jensen K, Schorr J, Davis HL, Fish Shellfish Immunol 1998 8 271 286 10.1006/fsim.1997.0133
6. DNA vaccines: an historical perspective and view to the future. Liu MA, Immunol Rev 2011 239 62 84 10.1111/j.1600-065X.2010.00980.x 21198665
7. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Raz ETH, Sato Y, Corr M, Dudler JA, Swain SL, Spiegelberg HL, Varson DA, Proc Natl Acad Sci U S A 1996 93 5141 5145 10.1073/pnas.93.10.5141 8643542
8. Role of transfection in the priming of cytotoxic T-cells by DNA-mediated immunization. Sbai H, Schneider J, Hill AV, Whalen RG, Vaccine 2002 20 3137 3147 10.1016/S0264-410X(02)00251-7 12163265
9. The relationship between major histocompatibility receptors and innate immunity in teleost fish. Dixon B, Stet RJM, Dev Comp Immunol 2001 25 683 699 10.1016/S0145-305X(01)00030-1 11602190
10. Luciferase expression 2 years after DNA injection in glass catfish (Kryptopterus bicirrhus). Dijkstra JM, Okamoto H, Ototake M, Nakanishi T, Fish Shellfish Immunol 2001 11 199 202 10.1006/fsim.2000.0303 11308080
11. Detection of supercoiled plasmid DNA and luciferase expression in Atlantic salmon (Salmo salar L.) 535 days after injection. Tonheim TC, Leirvik J, Løvoll M, Myhr AI, Bøgwald J, Dalmo RA, Fish Shellfish Immunol 2007 23 867 876 10.1016/j.fsi.2007.03.015 17502156
12. Inhibition of virus multiplication by foreign nucleic acid. Rotem Z, Cox RA, Isaacs A, Nature 1963 197 564 566 10.1038/197564a0 13975288
13. Immunotherapeutic uses of CpG oligodeoxynucleotides. Klinman DM, Nat Rev Immunol 2004 4 248 257
14. Genetic immunization of rainbow trout (Onchorhynchus mykiss) against infectious hematopoietic necrosis virus. Anderson ED, Mourich DV, Fahrenkrug SC, LaPatra S, Shepherd J, Leong JAC, Mol Mar Biol Biotechnol 1996 5 114 122 8680524
15. Naked DNA vaccination of Atlantic salmon Salmo salar against IHNV. Traxler GS, Anderson E, LaPatra SE, Richard J, Shewmaker B, Kurath G, Dis Aquat Organ 1999 38 183 190 10686669
16. Immunity to fish rhabdoviruses. Purcell MK, Laing KJ, Winton JR, Viruses 2012 4 140 166 10.3390/v4010140 22355456
17. Comprehensive gene expression profiling following DNA vaccination of rainbow trout against infectious hematopoietic necrosis virus. Purcell MK, Nichols KM, Winton JR, Kurath G, Thorgaard GH, Wheeler P, Hansen JD, Herwig RP, Park LK, Mol Immunol 2006 43 2089 2106 10.1016/j.molimm.2005.12.005 16426680
18. Transcription of immune genes upon challenge with viral hemorrhagic septicemia virus (VHSV) in DNA vaccinated rainbow trout (Oncorhynchus mykiss). Cuesta A, Tafalla C, Vaccine 2009 27 280 289 10.1016/j.vaccine.2008.10.029 18977266
19. Immunity induced shortly after DNA vaccination of rainbow trout against rhabdoviruses protects against heterologous virus but not against bacterial pathogens. Lorenzen N, Lorenzen E, Einer-Jensen K, LaPatra SE, Dev Comp Immunol 2002 26 173 179 10.1016/S0145-305X(01)00059-3 11696382
20. Time course study of in situ expression of antigens following DNA-vaccination against VHS in rainbow trout (Oncorhynchus mykiss Walbaum) fry. Lorenzen E, Lorenzen N, Einer-Jensen K, Brudeseth B, Evensen Ø Fish Shellfish Immunol 2005 19 27 41 10.1016/j.fsi.2004.10.009 15722229
21. Introduction of foreign genes into the tissue of live fish by direct injection and particle bombardment. Gomez-Chiarri M, Livingston SK, Muro-Cacho C, Sanders S, Levine RP, Dis Aquat Organ 1996 27 5 12
22. What happens to the DNA vaccine in fish? A review of current knowledge. Tonheim TC, Bøgwald J, Dalmo RA, Fish Shellfish Immunol 2008 25 1 18 10.1016/j.fsi.2008.03.007 18448358
23. Biotechnology and DNA vaccines for aquatic animals. Kurath G, Rev Sci Tech 2008 27 175 196 18666487
24. DNA vaccines in veterinary use. Redding L, Weiner DB, Expert Rev Vaccines 2009 8 1251 1276 10.1586/erv.09.77 19722897
25. A comparative review on European-farmed finfish RNA viruses and their vaccines. Gomez-Casado E, Estepa A, Coll JM, Vaccine 2011 29 2657 2671 10.1016/j.vaccine.2011.01.097 21320546
26. Development of a suicidal DNA vaccine for infectious hematopoietic necrosis virus (IHNV). Alonso M, Chiou PP, Leong JA, Fish Shellfish Immunol 2011 30 815 823 10.1016/j.fsi.2011.01.001 21232606
27. Specificity of DNA vaccines against the U and M genogroups of infectious hematopoietic necrosis virus (IHNV) in rainbow trout (Oncorhynchus mykiss). Penaranda MMD, LaPatra SE, Kurath G, Fish Shellfish Immunol 2011 31 43 51 10.1016/j.fsi.2011.03.003 21385613
28. Oral DNA vaccination of rainbow trout, Oncorhynchus mykiss (Walbaum), against infectious haematopoietic necrosis virus using PLGA [Poly(D, L-Lactic-Co-Glycolic Acid)] nanoparticles. Adomako M, St-Hilaire S, Zheng Y, Eley J, Marcum RD, Sealey W, Donahower BC, LaPatra S, Sheridan PP, J Fish Dis 2012 35 203 214 10.1111/j.1365-2761.2011.01338.x 22324344
29. Immunization of olive flounder (Paralichthys olivaceus) with an auxotrophic Edwardsiella tarda mutant harboring the VHSV DNA vaccine. Choi SH, Kim MS, Kim KH, Fish Shellfish Immunol 2012 33 569 574 10.1016/j.fsi.2012.06.013 22750026
30. Immunogenic and protective effects of an oral DNA vaccine against infectious pancreatic necrosis virus in fish. Heras AI D l, Rodríguez Saint-Jean S, Perez-Prieto SI, Fish Shellfish Immunol 2010 28 562 570 10.1016/j.fsi.2009.12.006 20034576
31. Comparison of vaccine efficacy for different antigen delivery systems for infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L.) in a cohabitation challenge model. Munang'andu HM, Fredriksen BN, Mutoloki S, Brudeseth B, Kuo T-Y, Marjara IS, Dalmo RA, Evensen Ø Vaccine 2012 30 4007 4016 10.1016/j.vaccine.2012.04.039 22537985
32. Superior protection conferred by inactivated whole virus vaccine over subunit and DNA vaccines against salmonid alphavirus infection in Atlantic salmon (Salmo salar L.). Xu C, Mutoloki S, Evensen Ø Vaccine 2012 30 3918 3928 10.1016/j.vaccine.2012.03.081 22504037
33. Construction and analysis of experimental DNA vaccines against megalocytivirus. Zhang M, Hu YH, Xiao ZZ, Sun Y, Sun L, Fish Shellfish Immunol 2012 33 1192 1198 10.1016/j.fsi.2012.09.010 22986024
34. Construction and evaluation of DNA vaccines encoding Edwardsiella tarda antigens. Jiao XD, Zhang M, Hu YH, Sun L, Vaccine 2009 27 5195 5202 10.1016/j.vaccine.2009.06.071 19596416
35. Construction and analysis of the immune effect of an Edwardsiella tarda DNA vaccine encoding a D15-like surface antigen. Sun Y, Liu CS, Sun L, Fish Shellfish Immunol 2011 30 273 279 10.1016/j.fsi.2010.10.020 21059395
36. Comparative study of the immune effect of an Edwardsiella tarda antigen in two forms: Subunit vaccine vs DNA vaccine. Sun Y, Liu CS, Sun L, Vaccine 2011 29 2051 2057 10.1016/j.vaccine.2011.01.013 21255681
37. Construction and comparative study of monovalent and multivalent DNA vaccines against Streptococcus iniae. Sun Y, Hu YH, Liu CS, Sun L, Fish Shellfish Immunol 2012 33 1303 1310 10.1016/j.fsi.2012.10.004 23063784
38. A Streptococcus iniae DNA vaccine delivered by a live attenuated Edwardsiella tarda via natural infection induces cross-genus protection. Sun Y, Hu YH, Liu CS, Sun L, Lett Appl Microbiol 2012 55 420 426
39. Immunogenicity and protective efficacy of Vibrio harveyi pcFlaA DNA vaccine in Epinephelus awoara. Qin YX, Su YQ, Wang SF, Yan QP, Chin J Oceanol Limn 2009 27 769 774
40. A bivalent Vibrio harveyi DNA vaccine induces strong protection in Japanese flounder (Paralichthys olivaceus). Hu YH, Sun L, Vaccine 2011 29 4328 4333 10.1016/j.vaccine.2011.04.021 21513763
41. Protection of red snapper (Lutjanus sanguineus) against Vibrio alginolyticus with a DNA vaccine containing flagellin flaA gene. Liang HY, Wu ZH, Jian JC, Huang YC, Lett Appl Microbiol 2011 52 156 161 10.1111/j.1472-765X. 2010.02981.x 21198695
42. Vaccination of rainbow trout, Oncorhynchus mykiss (Walbaum), with recombinant and DNA vaccines produced to Flavobacterium psychrophilum heat shock proteins 60 and 70. Plant KP, LaPatra SE, Cain KD, J Fish Dis 2009 32 521 534 10.1111/j.1365-2761.2009.01008.x 19460087
43. Codon changed immobilization antigen (iAg), a potent DNA vaccine in fish against Cryptocaryon irritans infection. Priya TAJ, Lin YH, Wang YC, Yang CS, Chang PS, Song YL, Vaccine 2012 30 893 903 10.1016/j.vaccine.2011.11.102 22154774
44. Towards a metalloprotease-DNA vaccine against piscine cryptobiosis caused by Cryptobia salmositica. Tan CW, Jesudhasan P, Woo PTK, Parasitol Res 2008 102 265 275 17932691
45. Approaches towards DNA vaccination against a skin ciliate parasite in fish. Jorgensen LV, Sigh J, Kania PW, Holten-Andersen L, Buchmann K, Clark T, Rasmussen JS, Einer-Jensen K, Lorenzen N, PloS One 2012 7 48129 10.1371/journal.pone.0048129 23144852
46. Analysis of DNA-vaccinated fish reveals viral antigen in muscle, kidney and thymus, and transient histopathologic changes. Garver KA, Conway CM, Elliott DG, Kurath G, Mar Biotechnol 2005 7 540 553 10.1007/s10126-004-5129-z 16075347
47. Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. Budker V, Budker T, Zhang GF, Subbotin V, Loomis A, Wolff JA, J Gene Med 2000 2 76 88 10809141
48. Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes. Zhong Q, Chinta DM, Pamujula S, Wang H, Yao X, Mandal TK, Luftig RB, J Nanobiotechnol 2010 8 6 10.1186/1477-3155-8-6
49. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Desmet CJ, Ishii KJ, Nat Rev Immunol 2012 12 479 491 10.1038/nri3247 22728526
50. The role of scavenger receptors in pathogen recognition and innate immunity. Mukhopadhyay S, Gordon S, Immunobiology 2004 209 39 49 10.1016/j.imbio.2004.02.004 15481139
51. Specific endocytosis and degradation of naked DNA in the endocardial cells of cod (Gadus morhua L.). Seternes T, Tonheim TC, Løvoll M, Bøgwald J, Dalmo RA, J Exp Biol 2007 210 2091 2103 10.1242/jeb.003186 17562882
52. The role of the macrophage scavenger receptor in immune stimulation by bacterial DNA and synthetic oligonucleotides. Zhu FG, Reich CF, Pisetsky DS, Immunology 2001 103 226 234 10.1046/j.1365-2567.2001.01222.x 11412310
53. Functional lipids and lipoplexes for improved gene delivery. Zhang XX, McIntosh TJ, Grinstaff MW, Biochimie 2012 94 42 58 10.1016/j.biochi.2011.05.005 21621581
54. Expression of transfected DNA depends on DNA topology. Weintraub H, Cheng PF, Conrad K, Cell 1986 46 115 122 10.1016/0092-8674(86)90865-2 3459589
55. Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production. Williams JA, Carnes AE, Hodgson CP, Biotechnol Adv 2009 27 353 370 10.1016/j.biotechadv.2009.02.003 19233255
56. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Davis HL, Millan CLB, Watkins SC, Gene Ther 1997 4 181 188 10.1038/sj.gt.3300380 9135731
57. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Tan Y, Li S, Pitt BR, Huang L, Hum Gene Ther 1999 10 2153 2161 10.1089/10430349950017149 10498247
58. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Qin LH, Ding YZ, Pahud DR, Chang E, Imperiale MJ, Bromberg JS, Hum Gene Ther 1997 8 2019 2029 10.1089/hum.1997.8.17- 2019 9414251
59. DNA vaccination against viral haemorrhagic septicaemia (VHS) in rainbow trout: size, dose, route of injection and duration of protection-early protection correlates with Mx expression. McLauchlan PE, Collet B, Ingerslev E, Secombes CJ, Lorenzen N, Ellis AE, Fish Shellfish Immunol 2003 15 39 50 10.1016/S1050-4648(02)00137-7 12787686
60. Strong expression of foreign genes following direct injection into fish muscle. Hansen E, Fernandes K, Goldspink G, Butterworth P, Umeda PK, Chang KC, FEBS Lett 1991 290 73 76 10.1016/0014-5793(91)81229-2 1915896
61. Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA. Doh SG, Vahlsing HL, Hartikka J, Liang X, Manthorpe M, Gene Ther 1997 4 648 663 10.1038/sj.gt.3300460 9282166
62. Nanogram quantities of a DNA vaccine protect rainbow trout fry against heterologous strains of infectious hematopoietic necrosis virus. Corbeil S, LaPatra SE, Anderson ED, Kurath G, Vaccine 2000 18 2817 2824 10.1016/S0264-410X(00)00078-5 10812224
63. The protective mechanisms induced by a fish rhabdovirus DNA vaccine depend on temperature. Lorenzen E, Einer-Jensen K, Rasmussen JS, Kjaer TE, Collet B, Secombes CJ, Lorenzen N, Vaccine 2009 27 3870 3880 10.1016/j.vaccine.2009.04.012 19427083
64. Introduction of genetic engineering in aquaculture: Ecological and ethical implications for science and governance. Myhr A, Dalmo RA, Aquaculture 2005 250 542 554 10.1016/j.aquaculture.2004.12.032
65. Technologies for enhanced efficacy of DNA vaccines. Saade F, Petrovsky N, Expert Rev Vaccines 2012 11 189 209 10.1586/erv.11.188 22309668
66. Modulation of the early immune response against viruses by a teleostean interferon regulatory factor-1 (IRF-1). Caipang CMA, Hirono I, Aoki T, Comp Biochem Physiol A Mol Integr Physiol 2009 152 440 446 10.1016/j.cbpa.2008.11.022 19101646
67. Specific uptake of plasmid DNA without reporter gene expression in Atlantic salmon (Salmo salar L.) kidney after intramuscular administration. Tonheim T, Dalmo RA, Bøgwald J, Seternes T, Fish Shellfish Immunol 2008 24 90 101 10.1016/j.fsi.2007.09.006 18023591
68. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. Tinsley-Bown AM, Fretwell R, Dowsett AB, Davis SL, Farrar GH, J Control Release 2000 66 229 241 10.1016/S0168-3659(99)00275-8 10742583
69. The formulation and immunisation of oral poly (DL-lactide-co-glycolide) microcapsules containing a plasmid vaccine against lymphocystis disease virus in Japanese flounder (Paralichthys olivaceus). Tian J, Sun X, Chen X, Yuc J, Qu L, Wang L, Int Immunopharmacol 2008 8 900 908 10.1016/j.intimp.2008.02.006 18442796
70. Poly(lactic-co-glycolic acid) nanoparticles as candidate DNA vaccine carrier for oral immunization of Japanese flounder (Paralichthys olivaceus) against lymphocystis disease virus. Tian J, Yu J, Fish Shellfish Immunol 2011 30 109 117 10.1016/j.fsi.2010.09.016 20920584
71. Transgene and immune gene expression following intramuscular injection of Atlantic salmon (Salmo salar L.) with DNA-releasing PLGA nano- and microparticles. Hølvold LB, Fredriksen BN, Bøgwald J, Dalmo RA, Fish Shellfish Immunol 2013 35 890 899 10.1016/j.fsi.2013.06.030 23850547
72. Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles. Malyala P, O'Hagan DT, Singh M, Adv Drug Deliv Rev 2009 61 218 225 10.1016/j.addr.2008.12.009 19168103
73. Polymeric materials for gene delivery and DNA vaccination. Nguyen DN, Green JJ, Chan JM, Longer R, Anderson DG, Adv Mater 2009 21 847 867 10.1002/adma.200801478
74. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Cohen H, Levy RJ, Gao J, Fishbein I, Kousaev V, Sosnowski S, Slomkowski S, Golomb G, Gene Ther 2000 7 1896 1905 10.1038/sj.gt.3301318 11127577
75. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Prabha S, Zhou WZ, Panyam J, Labhasetwar V, Int J Pharm 2002 244 105 115 10.1016/S0378-5173(02)00315-0 12204570
76. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P, Singh M, O'Hagan DT, Petrilli V, Tschopp J, O'Neill LA, Lavelle EC, Proc Natl Acad Sci U S A 2009 106 870 875 10.1073/pnas.0804897106 19139407
77. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Hedley ML, Curley J, Urban R, Nat Med 1998 4 365 368 10.1038/nm0398-365 9500615
78. Cationic microparticles: a potent delivery system for DNA vaccines. Singh M, Briones M, Ott G, O'Hagan D, Proc Natl Acad Sci U S A 2000 97 811 816 10.1073/pnas.97.2.811 10639162
79. Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression. Jang JH, Shea LD, J Control Release 2006 112 120 128 10.1016/j.jconrel.2006.01.013 16530876
80. Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model. Labhasetwar V, Bonadio J, Goldstein SA, Levy JR, Colloid Surface B 1999 16 281 290 10.1016/S0927-7765(99)00079-X
81. Formation and oral administration of alginate microspheres loaded with pDNAcoding for lymphocystis disease virus (LCDV) to Japanese flounder. Tian JY, Sun XQ, Chen XG, Fish Shellfish Immunol 2008 24 592 599 10.1016/j.fsi.2008.01. 009 18328731
82. Oral and parenteral vaccines against Flavobacterium columnare: evaluation of humoral immune response by ELISA and in vivo efficiency in Nile tilapia (Oreochromis niloticus). Leal CAG, Carvalho-Castro GA, Sacchetin PSC, Lopes CO, Moraes AM, Figueiredo HCP, Aquacult Int 2010 18 657 666 10.1007/s10499-009-9287- x
83. Chitosan microspheres as candidate plasmid vaccine carrier for oral immunisation of Japanese flounder (Paralichthys olivaceus). Tian J, Yu J, Sun X, Vet Immunol Immunopathol 2008 126 220 229 10.1016/j.vetimm.2008.07.002 18722672
84. Potential use of chitosan nanoparticles for oral delivery of DNA vaccine in Asian sea bass (Lates calcarifer) to protect from Vibrio (Listonella) anguillarum. Kumar SR, Ahmed VPI, Parameswaran V, Sudhakaran R, Babu VS, Hameed ASS, Fish Shellfish Immunol 2008 25 47 56 10.1016/j.fsi.2007.12.004 18479939
85. Biodegradable microparticles covalently linked to surface antigens of the scuticociliate parasite P. dicentrarchi promote innate immune responses in vitro. Leon-Rodriguez L, Luzardo-Alvarez A, Blanco-Mendez J, Lamas J, Leiro J, Fish Shellfish Immunol 2013 34 236 243 10.1016/j.fsi.2012.10.029 23142727
86. Vaccination effect of liposomes entrapped whole cell bacterial vaccine on immune response and disease protection in Epinephelus bruneus against Vibrio harveyi. Harikrishnan R, Kim JS, Balasundaram C, Heo MS, Aquaculture 2012 342 69 74
87. Antigen adsorbed surface modified poly-epsilon-caprolactone microspheres stimulates both adaptive and innate immune response in fish. Behera T, Swain P, Vaccine 2012 30 5278 5284 10.1016/j.vaccine.2012.05.028 22633870
88. Antigen adsorbed calcium phosphate nanoparticles stimulate both innate and adaptive immune response in fish, Labeo rohita H. Behera T, Swain P, Cell Immunol 2011 271 350 359 10.1016/j.cellimm.2011.07.015 21889128
89. Nanotechnology and risk: what are the issues? Myhr AI, Dalmo RA, Nanoethics: The Ethical and Social Implications of Nanotechnology New Jersey: John Wiley & Sons Inc, Allhoff FLP, Moor J, Weckert J, 2007 149 161
90. Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency. Gvili K, Benny O, Danino D, Machluf M, Biopolymers 2007 85 379 391 10.1002/bip.20697 17266128
91. Mapping uncertainties in the upstream: the case of PLGA nanoparticles in salmon vaccines. Nielsen KN, Fredriksen BN, Myhr AI, Nanoethics 2011 5 57 71 10.1007/s11569-011-0111-5 21603040
92. DNA vaccines for aquacultured fish. Lorenzen N, LaPatra SE, Rev Sci Tech 2005 24 201 213 16110889
93. DNA vaccination in aquaculture -Expert judgements of impact on environment and fish health. Gillund F, Tonheim T, Seternes T, Dalmo RA, Myhr AI, Aquaculture 2008 284 25 34 10.1016/j.aquaculture.2008.07.044
94. The road to licensure of a DNA vaccine. Salonius K, Simard N, Harland R, Ulmer JB, Curr Opin Investig Drugs 2007 8 635 641 17668365
95. Note for guidance: DNA vaccines non-amplifiable in Eukaryotic cells for veterinary use. EMEA, Committee for Veterinary Medicinal Products, 2001 [ http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 10/WC500004614.pdf ]
96. Concept paper on guidance for DNA vaccines. EMEA, Committee for the Medicinal Products for Human Use, 2012 [ http://www.ema.europa.eu/docs/en-GB/ document-library/Scientific-guideline/2012/03/WC500124898.pdf ]
97. Guidance for Industry. Considerations for Plasmid DNA Vaccines for Infectious Disease indications. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, 2007 [ http://www.fda.gov/downloads/ biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/ vaccines/ucm091968.pdf ]
98. Gene medication or genetic modification? The devil is in the details. Foss GS, Rogne S, Nat Biotechnol 2003 21 1280 1281 10.1038/nbt1103-1280 14595352